Strategic Partner for Biosimilars & Oncology

Connecting manufacturers with distributors across Eastern Europe, MENA, North Africa, South America, and South Asia through expert regulatory guidance and market access solutions.

15+

Target Countries

50+

Product Registrations

10+

Years Experience

About Orphamed

Your trusted partner in pharmaceutical market expansion across emerging markets

Bridging Manufacturers and Markets

Orphamed serves as a strategic bridge between pharmaceutical manufacturers and distributors across Eastern Europe, MENA, North Africa, South America, and South Asia regions.

With deep expertise in regulatory affairs, market access, and distribution management, we specialize in biosimilars and oncology products, ensuring seamless market entry and sustained growth.

Our comprehensive approach combines regulatory excellence with local market insights, delivering end-to-end solutions that accelerate your market expansion while maintaining the highest quality standards.

🌍

Global Reach

15+ target countries across three strategic regions

⚗️

Specialized Focus

Biosimilars and oncology expertise

📋

Regulatory Excellence

EU GMP and PICS GMP compliance

🤝

Partnership Approach

Long-term strategic relationships

Our Services

Comprehensive solutions for pharmaceutical market expansion

📋

Tender Management

Complete tender process management from preparation to award, ensuring competitive positioning and optimal outcomes.

  • Tender identification and analysis
  • Documentation preparation
  • Bid submission and follow-up
  • Contract negotiation support
🏛️

Regulatory Affairs

Expert guidance through complex regulatory landscapes, ensuring compliance and expedited approvals.

  • Product registration and licensing
  • Regulatory strategy development
  • Authority liaison and communication
  • Compliance monitoring
🚢

Export Management

End-to-end export solutions covering logistics, documentation, and supply chain optimization.

  • Logistics coordination
  • Export documentation
  • Supply chain optimization
  • Quality assurance
🔬

Technology Transfer

Seamless technology transfer services facilitating knowledge sharing and local manufacturing capabilities.

  • Process documentation
  • Technical training
  • Quality system implementation
  • Manufacturing support

Our Product Portfolio

Comprehensive range of biosimilars, oncological products, and radiology solutions

🧬 Biosimilars & Peptides

Advanced biologics for autoimmune disorders and oncology - Our Primary Focus

Etanercept

Rheumatoid Arthritis 25 mg, 50 mg - Solution for injection 4 Pre-filled Syringes Reference: Enbrel® | EU&PICS GMP

Denosumab

Osteoporosis 60 mg - Solution for injection 1 Pre-filled Syringe Reference: Prolia® | EU&PICS GMP

Eptacog Alfa

Hemophilia A & B 1.2 mg, 2.4 mg, 4.8 mg Lyophilized powder - 1 Vial Reference: NovoSeven® | EU&PICS GMP

Pembrolizumab

Oncology (Multiple Indications) 100 mg - Solution for infusion 1 Vial in box Reference: Keytruda® | EU&PICS GMP

Trastuzumab

HER2+ Breast Cancer 150 mg, 440 mg Lyophilized powder - 1 Vial Reference: Herceptin® | EU&PICS GMP

Adalimumab

Rheumatoid Arthritis, Psoriasis 40 mg/0.8 mL - Solution for injection Pre-filled Pen/Syringe Reference: Humira® | EU&PICS GMP

⚕️ Oncological Products

Comprehensive cancer treatment solutions

Irinotecan HCl

Colorectal Cancer 40 mg, 100 mg, 300 mg Concentrate solution - 1 vial in box Reference: Compostar® | PICS GMP

Bortezomib

Multiple Myeloma, Mantle Cell Lymphoma 1 mg, 3.5 mg Lyophilized powder - 1 vial in box Reference: Velcade® | PICS GMP

Paclitaxel

Breast, Ovarian, Lung Cancer 30 mg, 100 mg, 300 mg Concentrate solution - 1 vial Chemotherapy agent | PICS GMP

Docetaxel

Breast, Prostate, Lung Cancer 20 mg, 80 mg, 160 mg Concentrate solution - 1 vial Taxane derivative | PICS GMP

5-Fluorouracil

Colorectal, Breast, Gastric Cancer 250 mg, 500 mg, 1000 mg Injectable solution - 1 vial Antimetabolite | PICS GMP

Capecitabine

Colorectal, Breast Cancer 150 mg, 500 mg - Tablets 60 tablets per box Oral chemotherapy | PICS GMP

🔬 Radiology & Contrast Agents

Advanced imaging solutions for diagnostic procedures

Dotarem® (Gadoterate Meglumine)

MRI Contrast Agent - CNS 376.9 mg/mL (0.5 mmol/mL) Injectable solution - 1 vial in box Blood-brain barrier imaging | EU&PICS GMP

Gadavist® (Gadobutrol)

CNS MRI Contrast Enhancement 604.72 mg/mL (1.0 mmol/mL) Injectable solution - 1 vial in box Central nervous system imaging | EU&PICS GMP

Gadoterate Meglumine

General MRI Enhancement Multiple concentrations available Injectable solution - Various sizes Diagnostic imaging | EU&PICS GMP

Iopamidol

CT Contrast Agent 300 mg I/mL, 370 mg I/mL Injectable solution - Vials/Bottles Computed tomography imaging | EU&PICS GMP

Quality Assurance: All products manufactured under EU GMP & PICS GMP standards

Regulatory: Products available for registration in Eastern Europe, MENA, North Africa, South America, and South Asia regions

Complete Product Catalog

Download our comprehensive product portfolio with detailed specifications

Latest News & Updates

Stay informed about our latest developments and industry insights

15 JAN 2025

New Biosimilar Registration in South America

Orphamed successfully completes registration of key biosimilar products in major South American markets, expanding access to affordable biologics.

Read More →
08 JAN 2025

Partnership Expansion in North Africa

Strategic collaboration agreements signed with leading distributors across North African region to enhance market penetration.

Read More →
22 DEC 2024

EU GMP Certification Renewal

All manufacturing facilities successfully pass EU GMP inspection, maintaining highest quality standards for our product portfolio.

Read More →

Contact Us

Ready to expand your market presence? Get in touch with our experts

📍

Our Location

Turkey Office:
Orphamed İlaç ve Ecza Dış Tic. A.Ş.
Istanbul, Turkey

Serving regions:
Eastern Europe • MENA • South Asia
📞

Get In Touch

🕒

Business Hours

Monday - Friday:
9:00 AM - 6:00 PM (GMT+3)

Saturday & Sunday:
Closed
🔗

Follow Us

LinkedIn: Orphamed İlaç ve Ecza
Company:
Orphamed İlaç ve Ecza Dış Tic. A.Ş.